Tech Company M&A Transactions
SmartCells Acquisition
SmartCells, operating out of Beverly, was acquired by Merck. The transaction price was $500 million.
Transaction Overview
Company Name
Acquired By
Announced On
12/2/2010
Transaction Type
M&A
Amount
$500,000,000
M&A Terms
Under the terms of the agreement, Merck will acquire all outstanding stock of SmartCells, Inc. In return SmartCells shareholders will receive an upfront cash payment and be eligible to receive clinical development and regulatory milestones for products resulting from the transaction for potential aggregate payments in excess of $500 million.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
100 Cummings Center 419E
Beverly, MA 01915
USA
Beverly, MA 01915
USA
Phone
Website
Email Address
Overview
SmartInsulin consists of a layered, biocompatible and biodegradable polymer-therapeutic that is bound to an engineered glucose-binding molecule. Insulin is released from SmartInsulin only when the therapeutic is unbound by the presence of a specific glucose concentration.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Todd Zion
Browse more venture capital transactions:
Prev: 12/2/2010: SIGNiX venture capital transaction
Next: 12/2/2010: Sage Science venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs